Skip to main content
Clinical Trials/ISRCTN17197043
ISRCTN17197043
Completed
未知

A peer-delivered intervention to reduce the impact of psychosis stigma and discrimination: a feasibility randomised controlled trial

Greater Manchester Mental Health NHS Foundation Trust0 sites70 target enrollmentAugust 11, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Greater Manchester Mental Health NHS Foundation Trust
Enrollment
70
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 11, 2021
End Date
May 31, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 16\+ years
  • 2\. Meet ICD\-10 F20\-F29 Schizophrenia spectrum diagnosis, or be receiving services from Early Intervention Services (EIS)
  • 3\. Under the care of a mental health service with a care coordinator
  • 4\. Competent to provide written, informed consent (for ethical considerations)
  • 5\. At least a moderate level of self\-reported disclosure\-related distress screening scale (Rüsch et al., 2014\), as determined by scoring \>3 on the screening item
  • 6\. At least moderate levels of internalised stigma as determined by a a score of \=3 on at least one of the Internalised Stigma domains the Semi\-structured Interview Measure of Stigma (Wood et al., 2016\)

Exclusion Criteria

  • 1\. A primary diagnosis of alcohol or substance dependency (ICD\-10 F10 – F19 diagnosis), where this is clearly the cause of their psychotic symptoms. This does not exclude people who use substances or alcohol, only those with a primary diagnosis. This will be confirmed by the participant's care coordinator or psychiatrist
  • 2\. A diagnosis of moderate to severe learning disability, as confirmed by the participant's care coordinator or psychiatrist
  • 3\. An ICD\-10 diagnosis of organic psychosis, as confirmed by the participant's care coordinator or psychiatrist
  • 4\. Non\-English speaking, where this prevents engagement in informed written consent and interviews
  • 5\. Immediate risk to self or others as confirmed by the participant's care coordinator or psychiatrist

Outcomes

Primary Outcomes

Not specified

Similar Trials